Kyntra Bio Inc (KYNB) USD0.01

Sell:$7.01Buy:$7.12Price decreased$0.04 (0.57%)

NASDAQ:Price decreased0.64%
Market closed |
Prices delayed by at least 15 minutes
Sell:$7.01
Buy:$7.12
Change:Price decreased$0.04 (0.57%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$7.01
Buy:$7.12
Change:Price decreased$0.04 (0.57%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 June 2026
Thane WettigCEO
Sell
Tax related
198$6.71$1,328.5827,005
6 June 2026
David DeLuciaCFO
Sell
Tax related
52$6.71$348.924,377
14 May 2026
Thane WettigCEO
Buy
Regular purchase transaction
2,800$7.09$19,852.0027,203
6 March 2026
Thane WettigCEO
Sell
Tax related
277$6.84$1,894.6824,403
6 March 2026
David DeLuciaCFO
Sell
Tax related
60$6.84$410.404,429
6 December 2025
Thane WettigCEO
Sell
Tax related
259$8.42$2,180.7824,680
6 December 2025
David DeLuciaCFO
Sell
Tax related
52$8.42$437.844,489
17 November 2025
Thane WettigCEO
Buy
Regular purchase transaction
2,700$9.10$24,569.7324,939
13 November 2025
Thane WettigCEO
Buy
Regular purchase transaction
1,000$9.18$9,180.0022,239
6 September 2025
Thane WettigCEO
Sell
Tax related
248$12.10$3,000.8021,239

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 November 2025
Thane WettigCEO
Buy
Regular purchase transaction
2,700$9.10$24,569.7324,939
14 May 2026
Thane WettigCEO
Buy
Regular purchase transaction
2,800$7.09$19,852.0027,203
13 November 2025
Thane WettigCEO
Buy
Regular purchase transaction
1,000$9.18$9,180.0022,239
6 September 2025
Thane WettigCEO
Sell
Tax related
248$12.10$3,000.8021,239
6 December 2025
Thane WettigCEO
Sell
Tax related
259$8.42$2,180.7824,680

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.